These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28051840)

  • 1. Development and feasibility of the misuse, abuse, and diversion drug event reporting system (MADDERS®).
    Treister R; Trudeau JJ; Van Inwegen R; Jones JK; Katz NP
    Am J Addict; 2016 Dec; 25(8):641-651. PubMed ID: 28051840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of potentially abuse-related events in two phase 3 studies of NKTR-181, a novel opioid analgesic, using the MADDERS® system (Misuse, Abuse, and Diversion Drug Event Reporting System).
    Lanier RK; Henningfield JE; Gudin J; Rauck R; Elder H; Erpelding N; Treister R; Gimbel J; Tagliaferri M; Doberstein SK; Di Fonzo CJ; Lu L; Siddhanti S; Katz NP
    Curr Med Res Opin; 2019 Sep; 35(9):1513-1522. PubMed ID: 30932719
    [No Abstract]   [Full Text] [Related]  

  • 3. Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations.
    Smith SM; Jones JK; Katz NP; Roland CL; Setnik B; Trudeau JJ; Wright S; Burke LB; Comer SD; Dart RC; Dionne R; Haddox JD; Jaffe JH; Kopecky EA; Martell BA; Montoya ID; Stanton M; Wasan AD; Turk DC; Dworkin RH
    J Pain; 2017 Nov; 18(11):1287-1294. PubMed ID: 28479207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin misuse, abuse and diversion: a systematic review.
    Smith RV; Havens JR; Walsh SL
    Addiction; 2016 Jul; 111(7):1160-74. PubMed ID: 27265421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations.
    Smith SM; Dart RC; Katz NP; Paillard F; Adams EH; Comer SD; Degroot A; Edwards RR; Haddox DJ; Jaffe JH; Jones CM; Kleber HD; Kopecky EA; Markman JD; Montoya ID; O'Brien C; Roland CL; Stanton M; Strain EC; Vorsanger G; Wasan AD; Weiss RD; Turk DC; Dworkin RH
    Pain; 2013 Nov; 154(11):2287-2296. PubMed ID: 23792283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.
    McCauley JL; Leite RS; Melvin CL; Fillingim RB; Brady KT
    Subst Abus; 2016; 37(1):9-14. PubMed ID: 26675303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.
    Smith SM; Paillard F; McKeown A; Burke LB; Edwards RR; Katz NP; Papadopoulos EJ; Rappaport BA; Slagle A; Strain EC; Wasan AD; Turk DC; Dworkin RH
    J Pain; 2015 May; 16(5):389-411. PubMed ID: 25660826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?
    Kaye S; Darke S
    Addiction; 2012 Mar; 107(3):467-77. PubMed ID: 22313101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
    Cicero TJ; Inciardi JA; Muñoz A
    J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between source of diversion and prescription drug misuse, abuse, and dependence.
    Ford JA; Lacerenza C
    Subst Use Misuse; 2011; 46(6):819-27. PubMed ID: 21174499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse.
    Swank KA; Wu E; Kortepeter C; McAninch J; Levin RL
    J Am Pharm Assoc (2003); 2017; 57(2S):S63-S67. PubMed ID: 28073687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of laboratory assessment of drug abuse liability and implications for clinical development.
    Carter LP; Griffiths RR
    Drug Alcohol Depend; 2009 Dec; 105 Suppl 1():S14-25. PubMed ID: 19443137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradox of decreasing nonmedical opioid analgesic use and increasing abuse or dependence - An assessment of demographic and substance use trends, United States, 2003-2014.
    Jones CM
    Addict Behav; 2017 Feb; 65():229-235. PubMed ID: 27561431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?
    Peckham AM; Fairman KA; Sclar DA
    Expert Opin Drug Saf; 2018 May; 17(5):519-523. PubMed ID: 28985090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.